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Proliferating human cells exposed to ionizing radiation display a
variety of complex cellular responses, including a delay in normal
progression through the cell cycle at several checkpoints. These
checkpoints are regulated by mitogenic signal transduction
pathways and feedback loops which are themselves coordinately
regulated by external signals. In many cell types, the signalling
pathway which mediates transitory blockage of progression from
G1 to S phase following genotoxic stresses is dependent on the
p53 tumour suppressor protein. Irradiation of normal human
fibroblast cultures, for example, results in activation of p53 via a
post-translational stabilization mechanism. This, in turn, leads to
increased expression of the p21WAF1 gene, which encodes an
inhibitor of cyclin-dependent kinases that are required for G1/S
progression (El-Deiry et al, 1993; Brugarolas et al, 1995).
Radiation-induced activation of p53 has been reported to be miti-
gated by calphostin C, a specific inhibitor of protein kinase C,
suggesting the involvement of this kinase in the p53 pathway
(Khanna and Lavin, 1993). Using pharmacological inhibitors of
different protein kinases, we provided evidence that the radiation-
responsive signalling cascade regulating replicative DNA
synthesis (i.e. S phase checkpoint) in normal human fibroblasts
utilizes Ca2+/calmodulin-dependent protein kinase II (CaMKII)
but not protein kinase C (Mirzayans et al, 1995a). The role of
CaMKII in the p53-signalling pathway remains to be elucidated.
Ataxia telangiectasia (AT) is a recessive human genetic disease
featuring immunological, neurological and developmental abnor-
malities, cancer proneness and hypersensitivity to ionizing radia-
tion (Sedgwick and Boder, 1991; Lavin, 1993). Cells cultured
from AT patients exhibit impaired induction of p53 and defects in
all cell cycle checkpoints normally seen at early times post-
irradiation (Kastan et al, 1992; Beamish and Lavin, 1994). A gene
mutated in AT has been cloned and designated ATM (Savitsky et
al, 1995). One of the functional domains of the ATM protein has
significant homology with the lipid kinase domain of phospha-
tidylinositol (PI) 3-kinase (Savitsky et al, 1995), a cytoplasmic
signal transducer that participates in mitogenesis, cell transforma-
tion and other cellular processes involving protein tyrosine
kinases. PI 3-kinase and related proteins such as ATM and DNA-
dependent protein kinase (DNA-PK) play important roles in vital
biological processes including cellular responses to genotoxic
stress (Taylor, 1998). Accordingly, there is a great deal of interest
in pharmacological inhibitors of these kinases not only as a tool
for elucidating the function of the target proteins, but also for
exploring the possible clinical utility of such inhibitors as potentia-
tors of the cytotoxicity of antineoplastic agents.
The purpose of the present study was to assess the effects of two
protein kinase inhibitors, wortmannin and KN62, on the response
of normal human dermal fibroblast cultures to 60Co g radiation
in terms of cell survival and activation of S phase and G1/S
checkpoints. Wortmannin is an inhibitor of PI 3-kinase and PI
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Summary Wortmannin is a potent inhibitor of phosphatidylinositol (PI) 3-kinase and PI 3-kinase-related proteins (e.g. ATM), but it does not
inhibit the activity of purified calmodulin-dependent protein kinase II (CaMKII). In the present study, we compared the effects of wortmannin
and the CaMKII inhibitor KN62 on the response of normal human dermal fibroblast cultures to g radiation. We demonstrate that wortmannin
confers a phenotype on normal fibroblasts remarkably similar to that characteristic of cells homozygous for the ATM mutation. Thus
wortmannin-treated normal fibroblasts exhibit increased sensitivity to radiation-induced cell killing, lack of temporary block in transition from
G1 to S phase following irradiation (i.e. impaired G1/S checkpoint), and radioresistant DNA synthesis (i.e. impaired S phase checkpoint).
Wortmannin-treated cultures display a diminished capacity for radiation-induced up-regulation of p53 protein and expression of p21WAF1, a
p53-regulated gene involved in cell cycle arrest at the G1/S border; the treated cultures also exhibit decreased capacity for enhancement of
CaMKII activity post-irradiation, known to be necessary for triggering the S phase checkpoint. We further demonstrate that KN62 confers a
radioresistant DNA synthesis phenotype on normal fibroblasts and moderately potentiates their sensitivity to killing by g rays, without
modulating G1/S checkpoint, p53 up-regulation and p21WAF1 expression following radiation exposure. We conclude that CaMKII is involved in
the radiation responsive signalling pathway mediating S phase checkpoint but not in the p53-dependent pathway controlling G1/S checkpoint,
and that a wortmannin-sensitive kinase functions upstream in both pathways. © 1999 Cancer Research Campaign
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Correspondence to: R Mirzayans3-kinase-related proteins (Powis et al, 1994; Hartley et al, 1995;
Banin et al, 1998; Cliby et al, 1998), but it does not inhibit the
activity of purified CaMKII (Nakanishi et al, 1992). KN62, on
the other hand, is a potent and specific inhibitor of CaMKII
(Tokumitsu et al, 1990). We report that normal fibroblasts treated
with wortmannin exhibit an AT-like phenotype, with regards to
increased sensitivity to radiation cytotoxicity, mitigated G1/S
checkpoint, and radioresistant DNA synthesis. Wortmannin-
treated cultures also exhibit a diminished capacity for both up-
regulation of p53 protein and enhancement of CaMKII activity
following radiation exposure. We further demonstrate that the
CaMKII inhibitor, KN62, abrogates the radiation-induced S phase
checkpoint and moderately increases radiosensitivity in normal
fibroblasts. Unlike wortmannin, however, KN62 exerts no signifi-
cant effect on the G1/S checkpoint and on p53 up-regulation
induced by g rays.
MATERIALS AND METHODS
Cells and culture conditions
The normal human dermal fibroblast strain GM38 was obtained
from NIGMS Human Genetic Mutant Cell Repository (Camden,
NJ, USA). Cells were cultivated in thymidine (dThd)-free Ham’s
F12 medium supplemented with 10% (v/v) fetal bovine serum,
1m ML -glutamine, 100 IU ml–1 penicillin G and 100 mg ml–1
streptomycin sulphate in a 37°C chamber incubator providing a
humidified atmosphere of 5% carbon dioxide in air.
Radiation treatment
Exposure to 60Co g radiation was performed in a Gammacell
220 unit as described (Mirzayans et al, 1995b).
Chemicals
Wortmannin and 1-[N,O-bis(5-isoquinolinesulphonyl)-N-methyl-
L-tyrosyl]-4-phenylpiperazine (KN62) were purchased from
Biomol Research Laboratories, Inc. (Plymouth Meeting, PA,
USA). Stock solutions of these compounds (10 mM) were prepared
in dimethyl sulphoxide (DMSO) and stored at –70°C. To assess
the effects of kinase inhibitors on the response of human cells to g
radiation, cultures were treated with each reagent for 1 h prior to
irradiation and during post-irradiation incubation periods as
indicated. Control cultures were incubated in medium containing
0.1% (v/v) DMSO.
Clonogenic survival assay
Fibroblasts harvested in late logarithmic growth phase were plated
out at ~5 ´ 105 per 100-mm dish and incubated overnight. Cells
were treated with a kinase inhibitor for 1 h, exposed to g rays and
incubated in the same medium for 10 h. Their reproductive
capacity was determined using the feeder layer technique
described previously (Mirzayans et al, 1989).
DNA replicative synthesis assay
Cells were inoculated in 60-mm dishes (105 cells per dish) and
incubated overnight in growth medium and for an additional
18–20 h in medium containing 180 Bq ml–1 [methyl-14C]dThd
(stock specific activity, 2 ´ 109 Bq mmol–1). After removal of the
radioactive medium, cultures were incubated for 1 h in the pres-
ence or absence of a protein kinase inhibitor as indicated, exposed
to  g rays (or left unirradiated), and incubated for 1.5 h in the
same medium. Tritiated-dThd (5.5 ´ 105 Bq ml–1; specific activity,
3 ´ 1012 Bq mmol–1) was added to the culture medium during the
last 30-min of the post-irradiation incubation period. Cells in each
dish were then lysed in a 2% sodium dodecyl sulphate (SDS)
solution and the amount of trichloroacetic acid (TCA)-insoluble
radioactivity in each lysate was determined as described
(Mirzayans et al, 1995b). The level of DNA synthesis was
expressed as a percentage of the resulting 3H/14C ratios for
irradiated compared to unirradiated cultures.
Measurement of S phase index
Cells were seeded on sterile glass coverslips (placed in 35-mm
dishes) at ~5 ´ 104 cells in a final volume of 2 ml of dThd-free
medium. After incubation for 2 days, cultures were exposed to g
rays (or left unirradiated), incubated for various times in dThd-free
medium and then pulse-labelled for 0.5 h in medium containing
3.7 ´ 104 Bq [methyl-3H]dThd (specific activity, 2.4 ´ 1011 Bq
mmol–1) per ml. Cultures were incubated with or without a kinase
inhibitor for 1 h prior to irradiation and during the entire post-
irradiation period. The percentage of cells in S phase was deter-
mined by in situ autoradiography as described (Mirzayans et al,
1995b).
CaMKII assay
CaMKII activity in cellular extracts was determined by the method
of Mayford et al (1995) with minor modifications. GM38 fibro-
blasts were seeded in 150-mm dishes (1 ´ 106 cells per dish) and
incubated for 2 days in growth medium. The cells were incubated
in serum-free medium for 90 min and then exposed to g radiation
(or sham-treated). Cells were incubated in medium containing
wortmannin (10 mM) or DMSO for 1 h prior to and during irradia-
tion. After rinsing in ice-cold phosphate-buffered saline (PBS), the
cells were scraped into suspension and lysed for 30 min at 4°C in a
buffer containing 40 mM Tris–HCl (pH 7.4), 0.5 mM EGTA,
0.5 mM EDTA (pH 7.4), 200 mM sodium chloride, 1% NP-40, 
10 mg ml–1 leupeptin, 0.4 mM sodium molybdate,10 mM sodium
pyrophosphate, 20 mM glycerophosphate, 0.1 mM phenylmethyl-
sulphonyl fluoride (PMSF) and 2 mM 2-mercaptoethanol. CaMKII
reaction mixture contained 50 mM HEPES (pH 7.0), 10 mM
magnesium chloride, 100 mM bovine serum albumin, 100 mM ATP,
100 mCi ml–1 [g-32P]ATP, 2 mM EGTA, 1 mM b-mercaptoethanol,
0.5 mM protein kinase A (PKA) inhibitor, and 20 mM autocamtide-
2. Enzyme reactions were carried out at 37°C for 2 min in a final
volume of 100 ml. Thereaction was started by the addition of 10 ml
of cell extract and terminated by the addition of 100 ml of ice-
chilled 10% TCA. Precipitated protein was pelleted by centrifuga-
tion in a microfuge for 4 min. The supernatant was spotted onto
phosphocellulose filter discs (Gibco-BRL, Burlington, ON,
Canada), washed with water (three times, 10 min each), and dried.
The amount of 32P incorporated into the substrate (autocamtide-2)
was quantified by scintillation counting. Protein concentrations of
cell extracts were determined by the Bradford assay (Bio-Rad
Laboratories, Hercules, CA, USA).
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GM38 fibroblasts were seeded in 100-mm dishes (~5 ´ 105 per
dish) and incubated in growth medium for 2 days. The cells were
treated with a kinase inhibitor, exposed to g rays, and incubated for
3 h. The cells were then centrifuged and resuspended in lysis
buffer (62 mM Tris (pH 6.8), 10% glycerol, 2% SDS, 5%
b-mercaptoethanol, 0.003% bromophenol blue). Cellular proteins
were separated by 10% SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) (30 mg protein loaded per lane) and transferred to
Hybond-P membranes (Amersham Corp., Oakville, ON, Canada).
The membranes were washed for 1 h in blocking buffer (5% non-
fat dry Carnation milk in PBS), and incubated for 1 h in the same
buffer containing a p53-specific monoclonal antibody (1801) or a
p21-specific monoclonal antibody (Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA). Antibody reactions were visualized
by the Amersham chemiluminescence procedure using a horse-
radish peroxidase-conjugated goat anti-mouse IgG as the
secondary antibody (Santa Cruz Biotechnology Inc.), and quanti-
fied by a digitized image analyser (Palcic and Jaggi, 1990).
Northern blotting
RNA was isolated from fibroblast cultures using TRIzol reagent
(Gibco-BRL) according to the manufacturer’s directions. Total
RNA was resolved on 1.5% agarose-formaldehyde gels (20 mg
RNA per lane) and transferred to Hybond-N+ membranes
(Amersham). After baking at 80°C for 1 h, each membrane was
hybridized with 32P-dCTP-labelled probes generated using the
Oligolabeling Kit (Pharmacia Biotech Inc., Baie d’Urfe, PQ,
Canada), and exposed to a Kodak XAR-5 film at –70°C with an
intensifying screen. The intensity of the resulting bands (corre-
sponding to p21WAF1 or b-actin transcripts) appearing on the film
was quantified by a digitized image analyser (Palcic and Jaggi,
1990).
RESULTS
Accumulating evidence indicates that many tumour cell lines have
bypassed the usual mechanisms by which the cell cycle machinery
controls the proliferation of normal cells in response to radiation-
activated DNA damage (Nagasawa et al, 1995; Huang et al, 1996;
Mirzayans et al, 1997; Olivier et al, 1998). Olivier et al (1998), for
example, have reported a relaxed cell cycle arrest in human tumour
cell lines harbouring wild-type p53. Given that the objective of the
experiments described below was to compare the effects of
KN62 and wortmannin on cellular radiosensitivity and radiation-
activated G1/S and S phase checkpoints, these experiments were
performed with diploid normal human fibroblast cultures in order
to avoid possible complications associated with the use of tumour
cells due to aberrant operation of the cell cycle checkpoint
circuitry.
Radiosensitization of human fibroblasts by wortmannin
and KN62
Normal human (GM38) fibroblast cultures were incubated in the
presence or absence of a kinase inhibitor for 1 h and exposed to g
radiation. After incubation in the same medium for 10 h, the cells
were plated at appropriate densities (100–10 000 cells per 100-mm
dish) and allowed to form macroscopic colonies in the absence of
the drug. Both kinase inhibitors potentiated radiosensitivity in
normal fibroblasts (Figure 1). Following 2 Gy irradiation, for
example, clonogenic survival was reduced to 60% in control
cultures, 35% in cultures treated with KN62 and 20% in cultures
treated with wortmannin.
Differential effects of wortmannin and KN62 on
radiation-activated G1/S checkpoint
To assess the effects of wortmannin and KN62 on G1/S cell cycle
arrest, GM38 cultures were incubated with a 10 mM concentration
Effects of wortmannin and KN62 on cell cycle checkpoints 961
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Figure 1 Radiosensitization of GM38 fibroblasts by wortmannin and KN62.
Cells were treated with either wortmannin or KN62, each at 10 mM; control
cultures were incubated in medium containing 0.1% (v/v) DMSO. The cells
were then exposed to g rays, incubated in the same medium for 10 h and
assayed for clonogenic survival as described in Materials and Methods.
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Figure 2 Effects of wortmannin and KN62 on radiation-induced decreases
in S phase index in GM38 fibroblasts. Cultures were incubated for 1 h either
with or without a kinase inhibitor (10 mM). Following irradiation (10 Gy), the
cells were incubated in the same medium for various times as indicated;
[3H]-dThd was added to the culture medium during the last 30 min. Cells were
processed for autoradiography and the fraction of cells in S phase (i.e. those
with heavily labelled nuclei) was determined. Each datum point represents
the mean (± s.e.m.) of the values obtained in four samples from two
independent experiments; at least 500 cells were counted for each sampleof each drug for 1 h, exposed to 10 Gy of g radiation (or sham-
irradiated) and incubated for various times in the same medium.
Tritiated-dThd was added during the last 30 min of the incubation
period, after which the cells were processed for autoradiography
and the fraction of S phase cells (i.e. those with heavily labelled
nuclei) was determined. Under these conditions the ability of
human cells to activate the G1/S checkpoint in response to geno-
toxic stress can be accurately determined (Mirzayans et al, 1995b).
As expected (Mirzayans et al, 1995b), in control (solvent-treated)
cultures, the fraction of cells in S phase decreased as a function of
time after irradiation and reached ~20% of that in unirradiated
cultures by 10 h, indicating the activation of a G1/S checkpoint
pathway (Figure 2). Treatment of the fibroblast cultures with
wortmannin completely inhibited their ability to activate the G1/S
checkpoint (Figure 2), a response similar to that seen in AT cells
that were not incubated with a kinase inhibitor (Mirzayans et al,
1995b). In contrast to wortmannin, KN62 had no significant effect
on the radiation-activated G1/S checkpoint in normal fibroblasts
(Figure 2).
Wortmannin, but not KN62, mitigates the radiation-
induced up-regulation of p53 protein and expression of
the p21WAF1 gene
We next determined the effects of wortmannin and KN62 on
radiation-induced p53 protein up-regulation and p21WAF1 expres-
sion. To this end, GM38 fibroblasts were incubated in the presence
of a kinase inhibitor for 1 h and exposed to 5 Gy (or sham-
irradiated). Following incubation in the same medium for 3 h, the
cells were lysed and assayed for levels of p53 and p21 proteins as
well as p21WAF1 transcripts. As shown in Figure 3A, radiation
exposure resulted in an increase in the amount of p53 protein by
~threefold in control and KN62-treated cultures, but by only
1.2-fold in wortmannin-treated cultures. Radiation exposure also
increased the amounts of p21 protein (Figure 3B) and p21WAF1 tran-
scripts in control GM38 cells (Figure 4); wortmannin inhibited
p21WAF1 mRNA and p21 protein induction by g rays while KN62
was ineffective (Figures 3B and 4).
Both wortmannin and KN62 confer radioresistant DNA
synthesis on normal human fibroblasts
To compare the effects of KN62 and wortmannin on the radiation-
induced S phase checkpoint, GM38 fibroblasts were incubated
with an inhibitor for 1 h, exposed to varying doses of g rays and
incubated for 90 min in the same medium; [3H]dThd was added to
the culture medium during the last 30 min, whereupon the cells
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Figure 3 Effects of wortmannin and KN62 on radiation-induced increases
in p53 (A) and p21 (B) protein levels in GM38 fibroblasts. Cultures were
incubated for 1 h with a kinase inhibitor (each at 10 mM) prior to irradiation
with 0 or 5 Gy. Following a 3-h incubation in the same medium, the cells
were lysed and their p53 and p21 protein contents determined by Western
blotting. The data are expressed as normalized p53 (or p21) values for a
given treated sample relative to that for the control sample treated with
neither radiation nor a kinase inhibitor (set at 1). The means (± s.e.m.) of
three determinations are presented
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Figure 4 Effects of wortmannin and KN62 on radiation induction of p21WAF1
in GM38 fibroblasts. Cultures were treated as described in the legend of
Figure 3 and p21WAF1 mRNA transcripts were quantified by Northern blotting.
As a loading control, blots were stripped and reprobed for b-actin.
Representative blots showing p21WAF1 and b-actin transcripts as well as
relative p21WAF1 mRNA levels determined at 3-h post-irradiation are
presented. The densitometric measurements for p21WAF1 were normalized to
those for corresponding b-actin mRNA. The data are expressed as relative
values for each sample normalized to that of the control sample treated with
neither radiation nor a kinase inhibitor (set at 1). The means (± s.e.m.) of
three determinations are presentedwere lysed and the amount of [3H]dThd incorporated into genomic
DNA was determined. The results obtained are presented in
Figure 5. Irradiation of GM38 fibroblasts, which had been
incubated in the absence of a kinase inhibitor, caused a marked
reduction in the rate of [3H]dThd incorporation when compared to
unirradiated cultures. This reduction in DNA precursor uptake
seen at early times post-irradiation reflects a shutdown of the DNA
synthesis machinery, with respect to both initiating new replicons
and elongating those already in operation (Mirzayans et al, 1995b;
Painter, 1986). Cultures treated with either KN62 or wortmannin
exhibited radioresistant DNA synthesis (Figure 5), a phenotype
universally displayed by AT cells (Young and Painter, 1989).
Following 10 Gy irradiation, for example, the rate of DNA
synthesis decreased by 45% in control (solvent-treated) cultures
but only by 20% and 10% in cultures treated with either wort-
mannin or KN62 respectively (Figure 5).
Wortmannin mitigates the radiation-induced
enhancement of CaMKII activity
We demonstrated recently that exposure of normal human fibro-
blasts to g rays resulted in an increase in CaMKII activity, which is
required to activate the S phase checkpoint, and further that this
response could be mitigated by treatment of cells with KN62
(Famulski et al, submitted). The results in Figure 5 demonstrating
radioresistant DNA synthesis in wortmannin-treated normal
fibroblasts prompted us to investigate the effect of this drug on
radiation induction of CaMKII activity. As shown in Figure 6,
radiation exposure resulted in an increase in CaMKII activity by
~threefold in control cultures but only by ~1.5-fold in wort-
mannin-treated cultures.
DISCUSSION
In our previous studies, we showed that treatment of normal
human fibroblasts with antagonists of calmodulin (i.e. W7, W13)
or CaMKII (i.e. KN62) produces an AT-like, radioresistant DNA
synthesis phenotype (Mirzayans et al, 1995a). Moreover, exposure
of normal cells to g radiation led to a threefold enhancement of
CaMKII activity, while AT cells (which exhibit radioresistant
DNA synthesis) were defective in this response (Famulski et al,
submitted). These results suggest that radiation-induced suppres-
sion of DNA synthesis may be mediated through a CaMKII-
dependent signalling pathway. In the current study we have shown
that, like KN62, wortmannin also confers the radioresistant DNA
synthesis phenotype on normal fibroblasts (Figure 5) and mitigates
their ability to increase CaMKII activity following radiation
exposure (Figure 6). Given that wortmannin is ineffective in
Effects of wortmannin and KN62 on cell cycle checkpoints 963
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Figure 5 Effects of wortmannin and KN62 on the extent of inhibition of DNA
synthesis induced by g rays in GM38 fibroblasts. Cultures were incubated in
medium containing DMSO (control) or a kinase inhibitor (each at 10 mM) for
1 h prior to irradiation and for 90 min afterwards. Tritiated-dThd was added
during the last 30-min of the incubation period and the rate of DNA synthesis
was determined as described in Materials and Methods. Bars, s.e.m.
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Figure 6 The influence of wortmannin on the induction of CaMKII activity
by g rays. GM38 fibroblasts were incubated in medium containing either
DMSO (control) or 10 mM wortmannin for 1 h. Immediately after g irradiation
(0 or 10 Gy), the cells were lysed and assayed for CaMKII activity as
described in Materials and Methods. The means (± s.e.m.) of six
determinations from three independent experiments are presented
Ionizing radiation
ATM Wortmannin
p53 CaMKII KN62
S phase
checkpoint
G1/S
checkpoint
Figure 7 Proposed mechanisms of the inhibitory effects of wortmannin and
KN62 on radiation-induced cell cycle checkpoints. Exposure of normal
human fibroblasts to ionizing radiation results in activation of at least two
signalling pathways: (i) a p53-dependent pathway which causes a delay in
the transition from G1 to S phase (Kastan et al, 1992; Khanna and Lavin,
1993); and (ii) a p53-independent pathway which triggers a transient
suppression of replicon initiation and DNA chain elongation in cells in S
phase at the time of irradiation (Mirzayans et al, 1995a). A KN62-sensitive
kinase (i.e. CaMKII; Nakanishi et al, 1992) participates in the S phase
checkpoint pathway but not in the p53-dependent pathway, whereas a
wortmannin-sensitive kinase (e.g. ATM; Banin et al, 1998) functions
upstream in both pathwaysmodulating CaMKII activity when added directly to the CaMKII
reaction mixture (Nakanishi et al, 1992), we conclude that a
wortmannin-sensitive kinase and CaMKII participate in the same
signalling pathway controlling suppression of DNA synthesis in
irradiated cells, and that the former kinase probably functions
upstream of CaMKII in this pathway (also see Figure 7).
We have further demonstrated that wortmannin-treated normal
fibroblasts exhibit diminished capacity for both up-regulation of
p53 protein (Figure 3A) and expression of the p21WAF1 gene
(Figures 3B and 4) in response to radiation exposure. The treated
cultures also fail to activate the G1/S checkpoint post-irradiation
(Figure 2), a process known to be controlled by p21 in normal
human cells (El-Deiry et al, 1993; Brugarolas et al, 1995). Other
groups have found wortmannin to inhibit induction of the DNA-
binding activity of wild-type p53 protein in murine cells exposed
to ionizing radiation (Price and Youmell, 1996). Taken together,
these results suggest that a wortmannin-sensitive kinase functions
in the p53 signalling pathway which mediates the G1/S checkpoint
in irradiated cells. Contrary to our observation for wortmannin-
treated cells, KN62-treated cells responded normally to g irradia-
tion with respect to up-regulation of p53 protein, expression of the
p21WAF1 gene, and activation of the G1/S checkpoint (Figures 2–4).
Therefore, CaMKII, which is required for S phase arrest, does not
appear to play a significant role in the p53 signalling pathway that
controls the G1 arrest.
In keeping with its ability to inhibit several members of the
PI 3-kinase family, wortmannin can potentiate radiosensitivity not
only in normal human cells (this study), but also in DNA-PK-
deficient cells (Rosenzweig et al, 1997) and in ATM-deficient cells
(Rosenzweig et al, 1997). In addition, wortmannin has been
reported to enhance radiosensitivity in human tumour cell lines
harbouring wild-type or mutant p53 gene (Price and Youmell,
1996). Thus, although PI 3-kinase and related proteins represent
excellent targets for the radiosensitization of malignant cells, the
clinical utility of wortmannin may be limited owing to its ability to
inhibit multiple radiation-responsive pathways. Our current find-
ings, however, demonstrating potentiation of radiosensitivity in
human cells by KN62 and wortmannin (Figure 1), warrant further
studies to explore the clinical ramifications of pharmacological
inhibitors of CaMKII (e.g. KN62) and specific PI 3-kinase-related
proteins as antineoplastic drugs.
Several reports have demonstrated an inverse correlation
between the susceptibility of a variety of mammalian cell cultures
to killing by genotoxic agents and their ability to activate the S
phase checkpoint (Wang and Iliakis, 1992; Jung et al, 1995;
Mirzayans et al, 1995b; Morgan et al, 1997; Shao et al, 1997).
Accordingly, pharmacological abrogation of DNA damage-
induced cell cycle checkpoints (e.g. S phase arrest) by antagonists
of protein kinases has been proposed as an effective strategy for
selectively enhancing the cytotoxicity of therapeutic agents (Shao
et al, 1997). In light of this, we speculate that potentiation of
radiosensitivity by wortmannin and KN62 (Figure 1) may in part
be associated with abrogation of the radiation-induced S phase
arrest (Figure 5). Wortmannin is shown here to produce a greater
impact on radiation cytotoxicity than KN62 (Figure 1). This latter
observation is not surprising because KN62 specifically inacti-
vates CaMKII (Tokumitsu et al, 1990), while wortmannin not only
influences the radiation induction of CaMKII activity (Figure 6),
but also inhibits ATM, ATR and DNA-PK, all of which play vital
roles in the cellular responses to genotoxic stresses (Powis et al,
1994; Hartley et al, 1995; Banin et al, 1998; Cliby et al, 1998).
In summary, we have demonstrated that CaMKII, which is
known to be involved in the signalling pathway that mediates inhi-
bition of DNA synthesis in normal human fibroblasts exposed to g
radiation (Mirzayans et al, 1995a), does not play a significant role
in the p53-mediated pathway controlling the G1/S transition.
These results give credence to our previous findings which impli-
cated distinct mechanisms in the radiation-activated S phase and
G1/S checkpoints (also see Figure 7). A wortmannin-sensitive
kinase, on the other hand, appears to function upstream in both the
S phase and G1/S checkpoints (Figure 7). The wortmannin-sensi-
tive kinase proposed to function in these two pathways is most
likely ATM, because radiation responsive cell cycle checkpoints
are impaired in cells from AT patients (Beamish and Lavin, 1994),
and because among all wortmannin-sensitive kinases examined to
date only ATM participates in the radiation-induced S phase arrest
(Komatsu et al, 1993; Meyn, 1995; Cliby et al, 1998). Our results
also suggest that mitigation of the S phase checkpoint may
underlie, at least in part, the potentiation of radiosensitivity evoked
by both wortmannin and KN62 in normal human cells.
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